The determination of matrix metalloproteinase 9 activity and gene expression levels in Behcet's disease patients with aneurysmal complications

Clinical Rheumatology

Volumn 30, Issue 4, 2011, Pages 515-519

  Aksoy, Yasemin ^a   Ercan, Ayse ^a   Dalmizrak, Ozlem ^a   Canpinar, Hande ^a   Kartal Durmazlar, Selda Pelin ^b   Bayazit, Murat ^c  

^a HACETTEPE UNIVERSITY   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c GÜVEN HOSPITAL   (Turkey)

Author keywords

Aneurysm; Behcet's disease; Matrix metalloproteinase 9; MMP 9 activity; MMP 9 gene expression

Indexed keywords

GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AORTIC ANEURYSM, ABDOMINAL; BEHCET SYNDROME; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RNA, MESSENGER;

EID: 79954440698     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1559-3     Document Type: Article

References (36)

1. D Mendes M Correia M Barbedo, et al. 2009 Behçet's disease-a contemporary review J Autoimmun 32 3-4 178 188 19324519 10.1016/j.jaut.2009.02. 011 1:CAS:528:DC%2BD1MXls12qs7c%3D
2. SP Kartal Durmazlar A Akgul F Eskioglu 2008 Homocysteine may involve in the pathogenesis of Behcet's disease by inducing inflammation Mediat Inflamm 2008 407972 10.1155/2008/407972
3. SP Durmazlar G Bahar Ulkar F Eskioglu S Tatlican A Mert A Akgul 2009 Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement Int J Dermatol 48 3 259 264 19261013 10.1111/j.1365-4632.2009.03905.x 1:CAS:528:DC%2BD1MXktFGntbc%3D
4. Y Kalko M Basaran U Aydin 2005 The surgical treatment of arterial aneurysms in Behçet disease: a report of 16 patients J Vasc Surg 42 4 673 677 16242553 10.1016/j.jvs.2005.05.057 (Pubitemid 41483492)
5. ZH Iscan KM Vural M Bayazit 2005 Compelling nature of arterial manifestations in Behcet disease J Vasc Surg 41 1 53 58 15696044 10.1016/j.jvs.2004.09.018 (Pubitemid 40193340)
6. K Kasirajan JM Marek M Langsfeld 2001 Behcet's disease: endovascular management of a ruptured peripheral arterial aneurysm J Vasc Surg 34 6 1127 1129 11743572 10.1067/mva.2001.118585 1:STN:280:DC%2BD3MnpsFWlug%3D%3D (Pubitemid 33660678)
7. G Hatemi A Silman D Bang, et al. 2009 Management of Behcet's disease: a systematic literature review for the EULAR evidence based recommendations for the management of Behcet's disease Ann Rheum Dis 68 10 1528 1534 18420940 10.1136/ard.2008.087957 1:CAS:528:DC%2BD1MXhtlKqtbnP
8. B Annabi D Shédid P Ghosn, et al. 2002 Differential regulation of matrix metalloproteinase activities in abdominal aortic aneurysms J Vasc Surg 35 3 539 546 11877705 10.1067/mva.2002.121124 (Pubitemid 44718601)
9. E Choke MM Thompson J Dawson 2006 Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines Arterioscler Thromb Vasc Biol 26 2077 2082 16809548 10.1161/01.ATV.0000234944.22509.f9 1:CAS:528:DC%2BD28XotVWltr8%3D (Pubitemid 44253791)
10. M Kazi C Zhu J Roy, et al. 2005 Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm Arterioscler Thromb Vasc Biol 25 7 1341 1346 15845912 10.1161/01.ATV.0000166601.49954.21 1:CAS:528:DC%2BD2MXltlSisr8%3D (Pubitemid 40923349)
11. F Aziz H Kuivaniemi 2007 Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm Ann Vasc Surg 21 3 392 401 17484978 10.1016/j.avsg.2006.11.001 (Pubitemid 46678660)
12. TE Curry Jr KG Osteen 2003 The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle Endocr Rev 24 4 428 465 12920150 10.1210/er.2002-0005 1:CAS:528: DC%2BD3sXntlKjtbg%3D (Pubitemid 37056240)
13. R Pyo JK Lee JM Shipley, et al. 2000 Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 11 1641 1649 10841523 10.1172/JCI8931 1:CAS:528:DC%2BD3cXjvFWmt7s%3D (Pubitemid 30390315)
14. A Page-McCaw AJ Ewald Z Werb 2007 Matrix metalloproteinases and the regulation of tissue remodelling Nat Rev Mol Cell Biol 8 3 221 233 17318226 10.1038/nrm2125 1:CAS:528:DC%2BD2sXitVGrs74%3D
15. RW Thompson DR Holmes RA Mertens, et al. 1995 Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages J Clin Invest 96 1 318 326 7615801 10.1172/JCI118037 1:CAS:528:DyaK2MXmslyqs7s%3D
16. JR Elmore BF Keister DP Franklin 1998 Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms Ann Vasc Surg 12 3 221 228 9588507 10.1007/s100169900144 1:STN:280:DyaK1c3ksl2hsw%3D%3D (Pubitemid 28193978)
17. R Hyun-Jeong WC Parks 2007 Control of matrix metalloproteinase catalytic activity Matrix Biol 26 8 587 596 10.1016/j.matbio.2007.07.001 (Pubitemid 350180394)
18. International study group for Behcet's disease 1990 Criteria for diagnosis of Behcet's disease Lancet 335 1078 1080
19. BB Bhakta P Brennan TE James MA Chamberlain BA Noble AJ Silman 1999 Behcet's disease: evaluation of a new instrument to measure clinical activity Rheumatology 38 728 733 10501420 10.1093/rheumatology/38.8.728 1:STN:280:DyaK1MvivFGhug%3D%3D (Pubitemid 29507389)
20. G Lawton BB Bhakta MA Chamberlain A Tennant 2004 The Behcet's disease activity index Rheumatology 43 73 78 12890862 10.1093/rheumatology/keg453 1:STN:280:DC%2BD3sngtVSlug%3D%3D (Pubitemid 38088371)
21. I Sehgal TC Thompson 1999 Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines Mol Biol Cell 10 407 416 9950685 1:CAS:528:DyaK1MXitFGgtbg%3D (Pubitemid 29156481)
22. M Fähling A Steege A Perlewitz B Nafz R Mrowka PB Persson, et al. 2005 Role of nucleolin in posttranscriptional control of MMP-9 expression Biochim Biophys Acta 1731 32 40 16153722 (Pubitemid 41463598)
23. A Akgul 2008 Hormonal Changes in Vasculo-Behçet's Disease. Turkiye Klinikleri J Med Sci 28 599 600
24. GM Longo W Xiong TC Greiner Y Zhao N Fiotti BT Baxter 2002 Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysm J Clin Invest 110 625 632 12208863 1:CAS:528:DC%2BD38Xmslyitro%3D (Pubitemid 34988786)
25. OD Defawe A Colige CA Lambert, et al. 2003 TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas Cardiovasc Res 60 205 213 14522424 10.1016/S0008-6363(03)00513-3 1:CAS:528:DC%2BD3sXns12rs7Y%3D (Pubitemid 38373493)
26. N Sakalihasan Ph Delvenne BV Nusgens, et al. 1996 Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms J Vasc Surg 24 127 133 8691515 10.1016/S0741-5214(96)70153-2 1:STN:280:DyaK28zgsFagsg%3D%3D (Pubitemid 26271963)
27. MJ Hobeika RW Thompson BE Muhs, et al. 2007 Matrix metalloproteinases in peripheral vascular disease J Vasc Surg 45 4 849 857 17398401 10.1016/j.jvs.2006.09.066 (Pubitemid 46483940)
28. K Kizaki R Ito M Okada 2006 Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice Pharmacol Res 53 4 341 346 16455267 10.1016/j.phrs.2006.01.001 1:CAS:528:DC%2BD28Xjs1KjsL0%3D
29. JS Ikonomidis JA Jones JR Barbour, et al. 2007 Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves J Thorac Cardiovasc Surg 133 4 1028 1036 17382648 10.1016/j.jtcvs.2006.10.083 1:CAS:528: DC%2BD2sXkvFOgtLk%3D (Pubitemid 46435954)
30. S Pay T Abbasov H Erdem U Musabak I Simsek A Pekel A Akdogan A Sengul A Dinc 2007 Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Clin Exp Rheumatol 25 4 Suppl 45 70 75
31. YJ Lee SW Kang HJ Baek HJ Choi YD Bae EH Kang EY Lee EB Lee YW Song 2010 Association between matrix metalloproteinase 9 promoter polymorphisms and Behcet's disease Hum Immunol 71 717 722 20363273 10.1016/j.humimm.2010.03.009 1:CAS:528:DC%2BC3cXnvVeltLk%3D
32. DM Hovsepian SJ Ziporin MK Sakurai, et al. 2000 Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease J Vasc Interv Radiol 11 10 1345 1352 11099248 10.1016/S1051-0443(07)61315-3 1:STN:280: DC%2BD3Mzgs1egug%3D%3D
33. DR Lorelli JM Jean-Claude CJ Fox, et al. 2002 Response of plasma matrix metalloproteinase-9 to conventional abdominal aortic aneurysm repair or endovascular exclusion: implications for endoleak J Vasc Surg 35 5 916 922 12021707 10.1067/mva.2002.123676 (Pubitemid 44718559)
34. WD McMillan WH Pearce 1999 Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms J Vasc Surg 29 1 122 127 9882796 10.1016/S0741-5214(99)70363-0 1:STN:280:DyaK1M7gt1arsw%3D%3D
35. H Takagi H Manabe N Kawai, et al. 2009 Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysis Interact Cardiovasc Thorac Surg 9 3 437 440 19525292 10.1510/icvts.2009.208835
36. K Hamzaoui B Maître A Hamzaoui 2009 Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease Exp Rhoumatol 27 52 57